Veranova: A CDMO that manages complexity with confidence.
01 1Veranova, L.P.
02 1Curia Missouri, Inc.
03 1Curia New York, Inc.
04 1Cambrex Charles City, Inc
05 1Chattem Chemicals, Inc.
01 2Gamma Hydroxybutyric Acid
02 3Sodium Oxybate
01 4U.S.A
02 1Blank
Veranova: A CDMO that manages complexity with confidence.
NDC Package Code : 49812-0207
Start Marketing Date : 2010-06-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Curia - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.
NDC Package Code : 17180-2010
Start Marketing Date : 2002-07-17
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (13kg/13kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
Curia - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.
NDC Package Code : 65392-3417
Start Marketing Date : 2002-07-17
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-5950
Start Marketing Date : 2021-12-14
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 61960-0221
Start Marketing Date : 2017-12-06
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
44
PharmaCompass offers a list of Sodium Oxybate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Sodium Oxybate manufacturer or Sodium Oxybate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Oxybate manufacturer or Sodium Oxybate supplier.
A gamma-Hydroxybutyrate sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of gamma-Hydroxybutyrate sodium, including repackagers and relabelers. The FDA regulates gamma-Hydroxybutyrate sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. gamma-Hydroxybutyrate sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of gamma-Hydroxybutyrate sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A gamma-Hydroxybutyrate sodium supplier is an individual or a company that provides gamma-Hydroxybutyrate sodium active pharmaceutical ingredient (API) or gamma-Hydroxybutyrate sodium finished formulations upon request. The gamma-Hydroxybutyrate sodium suppliers may include gamma-Hydroxybutyrate sodium API manufacturers, exporters, distributors and traders.
click here to find a list of gamma-Hydroxybutyrate sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing gamma-Hydroxybutyrate sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for gamma-Hydroxybutyrate sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture gamma-Hydroxybutyrate sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain gamma-Hydroxybutyrate sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a gamma-Hydroxybutyrate sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of gamma-Hydroxybutyrate sodium suppliers with NDC on PharmaCompass.
We have 3 companies offering gamma-Hydroxybutyrate sodium
Get in contact with the supplier of your choice:
